|
|
| G
|
Abcb1
|
ATP binding cassette subfamily B member 1
|
severity
|
ISO
|
DNA:snp:exon:c.1236C>T (human)
|
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr 6:140,524,309...140,601,425
|
|
| G
|
Cat
|
catalase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29028686 |
|
NCBI chr 5:81,288,678...81,319,821
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
|
ISO
|
protein:increased expression:oronasal secretion (human)
|
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr16:18,455,804...18,458,870
|
|
| G
|
Cd40
|
CD40 molecule
|
|
ISO
|
protein:increased expression:lymphocyte
|
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr 5:152,891,252...152,906,394
|
|
| G
|
Cd40lg
|
CD40 ligand
|
|
ISO
|
protein:increased expression:lymphocyte
|
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:117,649,712...117,661,154
|
|
| G
|
Cldn3
|
claudin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33441633 |
|
NCBI chr16:19,056,630...19,058,195
|
|
| G
|
Cldn7
|
claudin 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33441633 |
|
NCBI chr 9:49,574,465...49,576,699
|
|
| G
|
Ctla4
|
cytotoxic T-lymphocyte associated protein 4
|
treatment
|
ISO
|
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr 4:134,979,731...134,985,687
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
protein:increased expression:nasal mucus
|
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chr 5:65,769,889...65,783,014
|
|
| G
|
Fcgr3a
|
Fc fragment of IgG receptor IIIa
|
susceptibility
|
ISO
|
DNA:polymorphism:exon:p.F158V(rs396991)(human)
|
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr10:50,197,313...50,207,557
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34624383 |
|
NCBI chr 9:40,879,210...41,198,259
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34624383 |
|
NCBI chr 3:72,735,221...72,850,794
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36127783 |
|
NCBI chr17:4,482,272...4,489,184
|
|
| G
|
Hrh1
|
histamine receptor H1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23333628 |
|
NCBI chr 6:32,036,807...32,123,141
|
|
| G
|
Ifng
|
interferon gamma
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with Asthma
|
RGD CTD |
PMID:12787306 PMID:18510219 PMID:29871060 |
RGD:10755770 RGD:7829803 |
NCBI chr 1:196,395,380...196,400,033
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:23253209 PMID:23883806 PMID:36127783 |
RGD:7364793 RGD:7364818 |
NCBI chr10:4,795,370...4,799,859
|
|
| G
|
Il13
|
interleukin 13
|
no_association susceptibility
|
ISO
|
DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) CTD Direct Evidence: marker/mechanism
|
RGD OMIM CTD |
PMID:12928861 |
RGD:8549516 |
NCBI chr 9:36,117,926...36,120,631
|
|
| G
|
Il13ra2
|
interleukin 13 receptor subunit alpha 2
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:98,167,999...98,229,291
|
|
| G
|
Il18
|
interleukin 18
|
severity no_association
|
ISO
|
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human)
|
RGD |
PMID:22840759 |
RGD:8655914 |
NCBI chr 8:45,029,011...45,055,185
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
protein:increased expression:nasal mucus
|
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chr 5:108,109,213...108,115,688
|
|
| G
|
Il2
|
interleukin 2
|
|
ISO
|
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 3:116,891,667...116,896,372
|
|
| G
|
Il4
|
interleukin 4
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662 PMID:36127783 |
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Il5
|
interleukin 5
|
treatment
|
ISO
|
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976 RGD:11522769 |
NCBI chr 9:36,201,293...36,204,023
|
|
| G
|
Itgb2
|
integrin subunit beta 2
|
treatment
|
ISO
|
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr18:872,085...909,423
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
|
ISO
|
DNA:SNP:promoter:g.-444A>C
|
RGD |
PMID:16730545 |
RGD:626168264 |
NCBI chr 9:32,900,641...32,902,690
|
|
| G
|
Mrc1
|
mannose receptor C-type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36127783 |
|
NCBI chr14:9,311,830...9,388,735
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
severity
|
ISO
|
mRNA,protein:decreased expression:nasal mucosa
|
RGD |
PMID:31425778 |
RGD:127345100 |
NCBI chr 3:64,443,492...64,447,959
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
ISO
|
mRNA, protein:increased expression:nasal cavity epithelium
|
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr 2:7,708,428...7,737,212
|
|
| G
|
Ocln
|
occludin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33441633 |
|
NCBI chr 3:157,902,627...157,949,884
|
|
| G
|
Pon1
|
paraoxonase 1
|
severity
|
ISO
|
protein:decreased activity:plasma (human)
|
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr 6:133,399,244...133,424,209
|
|
| G
|
Prkg1
|
protein kinase cGMP-dependent 1
|
|
ISO
|
protein:increased expression:nasal cavity epithelium
|
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr 2:30,872,391...31,757,664
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16979129 |
|
NCBI chr10:29,593,573...29,601,879
|
|
| G
|
Rora
|
RAR related orphan receptor A
|
ameliorates
|
ISO
|
DNA:SNP:multiple:multiple
|
RGD |
PMID:35636076 |
RGD:626469566 |
NCBI chr 8:62,996,100...63,719,057
|
|
| G
|
Scgb1a1
|
secretoglobin family 1A member 1
|
|
ISO
|
mRNA:decreased expression:nasal mucosa, lung
|
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr 2:8,857,238...8,860,667
|
|
| G
|
Scgb3a2
|
secretoglobin family 3A member 2
|
susceptibility
|
ISO
|
DNA:SNP: :rs7726552 (human)
|
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr15:23,978,703...23,981,753
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
ISO
|
mRNA:increased expression:nasal mucosa (mouse)
|
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr16:16,947,758...16,958,217
|
|
| G
|
Tacr1
|
tachykinin receptor 1
|
|
ISO
|
mRNA:increased expression:nasal mucosa
|
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr 6:63,634,443...63,795,694
|
|
| G
|
Tgfb1
|
transforming growth factor beta 1
|
treatment
|
ISO
|
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr 2:169,090,515...169,108,146
|
|
| G
|
Tlr2
|
toll like receptor 2
|
severity
|
ISO
|
mRNA:decreased expression:nasal mucosa: DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil:
|
RGD |
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057 |
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993 |
NCBI chr 3:69,727,695...69,733,850
|
|
| G
|
Tlr4
|
toll like receptor 4
|
no_association susceptibility severity treatment
|
ISO
|
protein:decreased expression:nasal mucosa: protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:polymorphism: :4216G>C(human) DNA:SNP: :rs1927911(human) DNA:polymorphism:cds:p.D299G(human)
|
RGD |
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
|
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993 |
NCBI chr 1:86,484,628...86,497,678
|
|
| G
|
Tlr9
|
toll like receptor 9
|
|
ISO
|
protein:decreased expression:nasal mucosa:
|
RGD |
PMID:22577387 |
RGD:7800740 |
NCBI chr 8:97,529,494...97,533,609
|
|
|
|
| G
|
Smchd1
|
structural maintenance of chromosomes flexible hinge domain containing 1
|
|
ISO
|
ClinVar Annotator: match by term: Arhinia, choanal atresia, and microphthalmia
|
OMIM ClinVar |
PMID:672092 PMID:5032329 PMID:6802865 PMID:8446727 PMID:8723126 PMID:11321738 PMID:16353241 PMID:23143600 PMID:23432817 PMID:23852095 PMID:25741868 PMID:26440771 PMID:26467025 PMID:26842768 PMID:28067909 PMID:28067911 PMID:28492532 PMID:31243061 PMID:31312724 More...
|
|
NCBI chr 4:180,803,089...180,930,996
|
|
|
|
| G
|
Kmt2d
|
lysine methyltransferase 2D
|
|
ISO
|
ClinVar Annotator: match by term: BRANCHIAL ARCH ABNORMALITIES, CHOANAL ATRESIA, ATHELIA, HEARING LOSS, AND HYPOTHYROIDISM SYNDROME | ClinVar Annotator: match by term: Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
|
OMIM ClinVar |
PMID:9536098 PMID:12002153 PMID:17576681 PMID:18414213 PMID:21658225 PMID:24728327 PMID:25590979 PMID:25741868 PMID:28492532 PMID:31949313 PMID:32083401 More...
|
|
NCBI chr 1:271,653,647...271,692,887
|
|
|
|
| G
|
Txnl4a
|
thioredoxin like 4A
|
|
ISO
|
ClinVar Annotator: match by term: Burn-McKeown syndrome | ClinVar Annotator: match by term: TXNL4A-related condition
|
OMIM ClinVar |
PMID:1342861 PMID:14564154 PMID:16523509 PMID:25434003 PMID:25741868 PMID:28492532 PMID:32735620 PMID:34713892 More...
|
|
NCBI chr15:52,003,860...52,018,833
|
|
|
|
| G
|
Kmt2d
|
lysine methyltransferase 2D
|
|
ISO
|
ClinVar Annotator: match by term: Choanal atresia
|
ClinVar |
PMID:25741868 PMID:31395954 |
|
NCBI chr 1:271,653,647...271,692,887
|
|
|
|
| G
|
Ptpn14
|
protein tyrosine phosphatase non-receptor type 14
|
|
ISO
|
ClinVar Annotator: match by term: Lymphedema-posterior choanal atresia syndrome | ClinVar Annotator: match by term: PTPN14-related condition
|
OMIM ClinVar |
PMID:20826270 PMID:25741868 PMID:28492532 |
|
NCBI chr10:67,797,609...67,942,067
|
|
|
|
| G
|
Edn1
|
endothelin 1
|
|
ISO
|
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
|
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr14:61,273,066...61,279,563
|
|
|
|
| G
|
Cd8a
|
CD8 subunit alpha
|
ameliorates
|
ISO
|
protein:decreased expression:blood, T cell (human)
|
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr 6:74,383,243...74,388,142
|
|
| G
|
Cdhr3
|
cadherin related family member 3
|
|
ISO
|
DNA:SNP:intron:rs6967330
|
RGD |
PMID:34076350 |
RGD:626467892 |
NCBI chr 7:46,379,159...46,439,272
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
treatment
|
ISO
|
DNA:SNP: :rs37973
|
RGD |
PMID:30256538 |
RGD:628359914 |
NCBI chr 6:129,816,197...129,883,811
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
susceptibility
|
ISO
|
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
|
RGD |
PMID:16549749 |
RGD:8549791 |
NCBI chr 5:12,857,104...12,861,509
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
|
ISO
|
mRNA:increased expression:sinonasal mucosa
|
RGD |
PMID:15940133 |
RGD:626168282 |
NCBI chr 9:32,900,641...32,902,690
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
|
ISO
|
protein:decreased activity:serum:
|
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr 2:30,336,702...30,342,648
|
|
| G
|
Prg2
|
proteoglycan 2, pro eosinophil major basic protein
|
disease_progression
|
ISO
|
associated with Nasal Polyps;
|
RGD |
PMID:24450586 |
RGD:13506943 |
NCBI chr 5:62,348,493...62,351,507
|
|
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr 6:30,246,881...30,296,065
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
treatment
|
ISO
|
DNA:SNP: :rs37973
|
RGD |
PMID:30256538 |
RGD:628359914 |
NCBI chr 6:129,816,197...129,883,811
|
|
| G
|
Il4
|
interleukin 4
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Il5
|
interleukin 5
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr 9:36,201,293...36,204,023
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr 9:32,900,641...32,902,690
|
|
| G
|
Ptgds
|
prostaglandin D2 synthase
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr 5:11,713,729...11,716,149
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
treatment
|
ISO
|
|
RGD |
PMID:23751068 |
RGD:626419675 |
NCBI chr10:29,593,573...29,601,879
|
|
| G
|
Spink5
|
serine peptidase inhibitor Kazal type 5
|
|
ISO
|
mRNA, protein:decreased expression:nasal cavity mucosa associated with aspirin-induced respiratory disease;mRNA:decreased expression:nasal cavity mucosa
|
RGD |
PMID:18588753 PMID:22570283 |
RGD:628359029 RGD:628359036 |
NCBI chr 3:121,162...181,554
|
|
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
treatment
|
ISO
|
DNA:SNP: :rs37973
|
RGD |
PMID:30256538 |
RGD:628359914 |
NCBI chr 6:129,816,197...129,883,811
|
|
| G
|
Spink5
|
serine peptidase inhibitor Kazal type 5
|
|
ISO
|
protein:decreased expression:nose, oronasal secretion mRNA, protein:decreased expression:nasal cavity epithelium
|
RGD |
PMID:27779422 |
RGD:628359037 |
NCBI chr 3:121,162...181,554
|
|
|
|
| G
|
Clu
|
clusterin
|
|
ISO
|
|
RGD |
PMID:19903339 |
RGD:9014708 |
NCBI chr12:58,463,019...58,475,194
|
|
|
|
| G
|
Sox2
|
SRY-box transcription factor 2
|
|
ISO
|
DNA:amplification
|
RGD |
PMID:23544055 |
RGD:8661654 |
NCBI chr 3:119,179,925...119,182,383
|
|
| G
|
Tp53
|
tumor protein p53
|
|
ISO
|
|
RGD |
PMID:19950227 |
RGD:8547762 |
NCBI chr 9:49,190,388...49,201,759
|
|
|
|
| G
|
Abcb1
|
ATP binding cassette subfamily B member 1
|
severity
|
ISO
|
Nasal Type;protein:increased expression:nasal cavity (human)
|
RGD |
PMID:18756548 |
RGD:8657087 |
NCBI chr 6:140,524,309...140,601,425
|
|
| G
|
Cd274
|
CD274 molecule
|
disease_progression
|
ISO
|
associated with Epstein-Barr Virus Infections
|
RGD |
PMID:27595782 |
RGD:41412182 |
NCBI chr 2:29,452,186...29,466,469
|
|
| G
|
Cflar
|
CASP8 and FADD like apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15924153 |
|
NCBI chr 4:133,705,160...133,753,373
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
|
ISO
|
DNA:insertion, deletions:cds:multiple (human)
|
RGD |
PMID:12466128 |
RGD:8662407 |
NCBI chr 2:33,897,209...33,930,625
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
treatment
|
ISO
|
associated with ethmoid sinus cancer and Neoplasm Metastasis
|
RGD |
PMID:29496492 |
RGD:151708712 |
NCBI chr 9:37,340,219...37,348,316
|
|
| G
|
Jak3
|
Janus kinase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22705984 PMID:23689514 |
|
NCBI chr13:13,277,803...13,290,206
|
|
| G
|
Prdm1
|
PR/SET domain 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:24438193 |
RGD:150530467 |
NCBI chr18:44,232,039...44,252,505
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
protein:increased expression:nasal cavity (human)
|
RGD |
PMID:17225522 |
RGD:153298933 |
NCBI chr 9:60,177,560...60,203,269
|
|
| G
|
Stat5b
|
signal transducer and activator of transcription 5B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29200404 |
|
NCBI chr 9:60,070,479...60,141,642
|
|
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr 4:7,942,802...7,945,933
|
|
| G
|
Alb
|
albumin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19389874 |
|
NCBI chr11:3,904,698...3,920,100
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
|
ISO
|
protein:increased expression:nasal turbinate
|
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr16:4,574,947...4,597,401
|
|
| G
|
Cat
|
catalase
|
|
ISO
|
protein:decreased expression:plasma
|
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr 5:81,288,678...81,319,821
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
|
ISO
|
mRNA:increased expression:Nasal Mucosa
|
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 8:115,176,474...115,177,595
|
|
| G
|
Cd40
|
CD40 molecule
|
|
ISO
|
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr 5:152,891,252...152,906,394
|
|
| G
|
Cd86
|
CD86 molecule
|
|
ISO
|
protein:increased expression:nasal mucosa, dendritic cell (human)
|
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr 4:21,469,526...21,512,850
|
|
| G
|
Egr1
|
early growth response 1
|
|
ISO
|
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
|
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr15:9,495,054...9,499,032
|
|
| G
|
F2rl1
|
F2R like trypsin receptor 1
|
|
ISO
|
|
RGD |
PMID:17727088 |
RGD:4892590 |
NCBI chr 3:222,689,461...222,702,301
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
mRNA, protein:increased expression: nasal mucosa
|
RGD |
PMID:16540907 |
RGD:4145406 |
NCBI chr17:4,482,272...4,489,184
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human)
|
RGD |
PMID:19047814 PMID:19968652 |
RGD:4145464 RGD:4145520 |
NCBI chr 8:17,279,224...17,290,965
|
|
| G
|
Ifngr1
|
interferon gamma receptor 1
|
|
ISO
|
DNA: SNP: Leu467Pro
|
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr 2:216,963,207...216,981,834
|
|
| G
|
Il13
|
interleukin 13
|
|
ISO
|
mRNA, protein:increased expression:nasal mucosa
|
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr 9:36,117,926...36,120,631
|
|
| G
|
Il18
|
interleukin 18
|
susceptibility
|
ISO
|
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
|
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr 8:45,029,011...45,055,185
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
|
ISO
|
DNA:polymorphism:exon:c.4845G>T (human)
|
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr 5:108,058,889...108,069,183
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
|
ISO
|
|
RGD |
PMID:18637763 |
RGD:5037238 |
NCBI chr 4:116,514,784...116,555,966
|
|
| G
|
Il2
|
interleukin 2
|
|
ISO
|
protein:decreased expression:serum:
|
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 3:116,891,667...116,896,372
|
|
| G
|
Il4
|
interleukin 4
|
treatment
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:9237816 PMID:15329007 PMID:21171297 |
RGD:5128559 RGD:7829804 RGD:7829817 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Il5
|
interleukin 5
|
|
ISO
|
protein: increased levels: sputum
|
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr 9:36,201,293...36,204,023
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
protein:increased expression:nasal mucosa:
|
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 5:153,004,445...153,048,368
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
protein:increased expression:nasal mucosa
|
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr 9:91,490,611...91,526,596
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
ISO
|
DNA:snp:promoter:g.-786T>C (human)
|
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr 6:153,557,887...153,577,422
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3 group C member 1
|
|
ISO
|
protein:altered expression:nasal mucosa
|
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr15:5,431,948...5,522,978
|
|
| G
|
Pparg
|
peroxisome proliferator activated receptor gamma
|
|
ISO
|
mRNA, protein:increased expression:nasal mucosa (human)
|
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr 6:31,222,604...31,347,537
|
|
| G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
|
ISO
|
protein:increased expression:respiratory system epithelium
|
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 5:13,224,081...13,245,665
|
|
| G
|
Tbxa2r
|
thromboxane A2 receptor
|
treatment
|
ISO
|
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr 1:153,556,812...153,560,110
|
|
|
|
| G
|
Adam33
|
ADAM metallopeptidase domain 33
|
susceptibility
|
ISO
|
DNA:SNPs: :multiple (human)
|
RGD |
PMID:15298558 PMID:18778489 |
RGD:4145378 RGD:4145383 |
NCBI chr 5:110,787,667...110,799,663
|
|
| G
|
Ang
|
angiogenin
|
|
ISO
|
protein:increased expression:sputum
|
RGD |
PMID:19178538 |
RGD:6892723 |
NCBI chr12:72,208,247...72,208,881
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
|
ISO
|
|
RGD |
PMID:12165532 |
RGD:5129220 |
NCBI chr 7:123,263,513...123,265,973
|
|
| G
|
Bdkrb2
|
bradykinin receptor B2
|
|
ISO
|
|
RGD |
PMID:1890650 PMID:11149999 |
RGD:4891033 RGD:4891044 |
NCBI chr 7:123,225,047...123,254,809
|
|
| G
|
Bdnf
|
brain derived neurotrophic factor
|
susceptibility
|
ISO
|
DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:20464992 PMID:21723144 |
RGD:4891116 RGD:8655967 |
NCBI chr 5:87,969,541...88,020,106
|
|
| G
|
C3
|
complement C3
|
|
ISO
|
mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:17345707 PMID:20109314 |
RGD:5129524 RGD:5129539 |
NCBI chr 4:88,610,382...88,636,268
|
|
| G
|
C3ar1
|
complement C3a receptor 1
|
severity
|
ISO
|
protein:increased expression:nasal cavity
|
RGD |
PMID:18538384 |
RGD:5129559 |
NCBI chr 6:24,251,703...24,253,209
|
|
| G
|
C5ar1
|
complement C5a receptor 1
|
|
ISO
|
|
RGD |
PMID:18538384 |
RGD:5129559 |
NCBI chr 2:172,803,089...172,813,257
|
|
| G
|
Casp1
|
caspase 1
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:12396474 PMID:20974310 |
RGD:5130187 RGD:5130192 |
NCBI chr 8:2,211,760...2,221,443
|
|
| G
|
Cat
|
catalase
|
treatment
|
ISO
|
protein:increased activity:blood,nasal cavity mucosa:
|
RGD |
PMID:21541033 |
RGD:9479054 |
NCBI chr 5:81,288,678...81,319,821
|
|
| G
|
Ccl1
|
C-C motif chemokine ligand 1
|
|
ISO
|
mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 9:88,316,846...88,319,500
|
|
| G
|
Ccl17
|
C-C motif chemokine ligand 17
|
|
ISO
|
protein:increased expression:blood, mononuclear cell
|
RGD |
PMID:17517104 |
RGD:4145498 |
NCBI chr17:1,686,327...1,696,183
|
|
| G
|
Ccl19
|
C-C motif chemokine ligand 19
|
|
ISO
|
|
RGD |
PMID:17947663 |
RGD:5130909 |
NCBI chr 1:3,760,442...3,762,403
|
|
| G
|
Ccl22
|
C-C motif chemokine ligand 22
|
|
ISO
|
protein:increased expression:blood, mononuclear cell
|
RGD |
PMID:17517104 |
RGD:4145498 |
NCBI chr17:1,634,770...1,640,980
|
|
| G
|
Ccl24
|
C-C motif chemokine ligand 24
|
|
ISO
|
DNA:SNPs: :179T>C, 275C>T (human) mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:15580493 PMID:17982926 |
RGD:4145109 RGD:4891493 |
NCBI chr16:18,442,125...18,444,347
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
|
ISO
|
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
|
RGD |
PMID:15580493 PMID:24989688 |
RGD:11531119 RGD:4891493 |
NCBI chr16:18,455,804...18,458,870
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
susceptibility
|
ISO
|
Rhinitis, Allergic, Seasonal; DNA:SNP:cds:p.V64I (human)
|
RGD |
PMID:17135764 |
RGD:4145111 |
NCBI chr 8:115,176,474...115,177,595
|
|
| G
|
Cd14
|
CD14 molecule
|
resistance susceptibility
|
ISO
|
DNA:polymorphism:promoter:c. -159c>T (human)
|
RGD |
PMID:16950285 PMID:20109306 |
RGD:4144795 RGD:4144810 |
NCBI chr15:7,657,467...7,659,320
|
|
| G
|
Cd28
|
CD28 molecule
|
|
ISO
|
|
RGD |
PMID:21356099 |
RGD:5131612 |
NCBI chr 4:134,828,884...134,854,658
|
|
| G
|
Cd80
|
CD80 molecule
|
|
ISO
|
|
RGD |
PMID:21108691 |
RGD:5132622 |
NCBI chr 4:23,411,721...23,430,767
|
|
| G
|
Cdc42
|
cell division cycle 42
|
|
ISO
|
mRNA:increased expression:nasal turbinate
|
RGD |
PMID:19432938 |
RGD:5688273 |
NCBI chr 1:20,859,956...20,878,384
|
|
| G
|
Crhr2
|
corticotropin releasing hormone receptor 2
|
|
ISO
|
mRNA, protein:increased expression:nasal cavity epithelium
|
RGD |
PMID:17597629 |
RGD:5130940 |
NCBI chr 6:85,957,104...85,984,188
|
|
| G
|
Ctla4
|
cytotoxic T-lymphocyte associated protein 4
|
|
ISO
|
protein:increased expression:T cell
|
RGD |
PMID:17625281 |
RGD:4891512 |
NCBI chr 4:134,979,731...134,985,687
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:14657873 |
RGD:4891906 |
NCBI chr17:1,660,099...1,671,117
|
|
| G
|
Cxcl6
|
C-X-C motif chemokine ligand 6
|
|
ISO
|
protein:increased expression:nasal mucus
|
RGD |
PMID:20659080 |
RGD:4892030 |
NCBI chr11:4,198,515...4,199,521
|
|
| G
|
Cysltr1
|
cysteinyl leukotriene receptor 1
|
|
ISO
|
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:15379985 PMID:16689996 PMID:17627772 PMID:18946234 |
RGD:4781451 RGD:4783198 RGD:4847512 RGD:4888516 |
NCBI chr X:72,447,173...72,448,254
|
|
| G
|
Cysltr2
|
cysteinyl leukotriene receptor 2
|
|
ISO
|
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:16689996 |
RGD:4783198 |
NCBI chr12:51,379,857...51,381,005
|
|
| G
|
Fcer1a
|
Fc fragment of IgE receptor Ia
|
|
ISO
|
|
RGD |
PMID:20650300 |
RGD:5128714 |
NCBI chr10:52,268,876...52,274,929
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
|
ISO
|
mRNA, protein:increased expression:nasal cavity mucosa (rat)
|
RGD |
PMID:28146064 |
RGD:13204839 |
NCBI chr16:17,053,579...17,068,682
|
|
| G
|
Hdc
|
histidine decarboxylase
|
|
ISO
|
DNA:SNP: :p.E644D (rs2073440) (human)
|
RGD |
PMID:15054596 PMID:20608921 |
RGD:5128884 RGD:5143921 |
NCBI chr 5:105,431,093...105,465,527
|
|
| G
|
Hnmt
|
histamine N-methyltransferase
|
no_association
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17651147 |
RGD:5128885 |
NCBI chr 5:33,547,298...33,580,148
|
|
| G
|
Hrh1
|
histamine receptor H1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12167471 |
|
NCBI chr 6:32,036,807...32,123,141
|
|
| G
|
Il13
|
interleukin 13
|
susceptibility disease_progression
|
ISO
|
DNA:polymorphism: :rs1800925 (human) associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) mRNA:increased expression:nose
|
RGD |
PMID:16120094 PMID:17088137 PMID:20358028 PMID:20484924 PMID:20696593 |
RGD:4145454 RGD:4145534 RGD:4145767 RGD:4159171 RGD:4206706 |
NCBI chr 9:36,117,926...36,120,631
|
|
| G
|
Il13ra2
|
interleukin 13 receptor subunit alpha 2
|
|
ISO
|
|
RGD |
PMID:17088137 |
RGD:4159171 |
NCBI chr X:98,167,999...98,229,291
|
|
| G
|
Il15
|
interleukin 15
|
|
ISO
|
|
RGD |
PMID:16750998 |
RGD:5000756 |
NCBI chr17:17,773,661...17,839,657
|
|
| G
|
Il16
|
interleukin 16
|
|
ISO
|
protein:increased expression:serum protein:increased expression:nasal cavity epithelium, serum
|
RGD |
PMID:18254318 PMID:19295235 |
RGD:5024931 RGD:5024932 |
NCBI chr 2:116,606,788...116,686,078
|
|
| G
|
Il18
|
interleukin 18
|
disease_progression
|
ISO
|
rhinitis allergic, seasonal; protein:increased expression:plasma protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid protein:increased expression:serum
|
RGD |
PMID:15934281 PMID:17305282 PMID:17323858 |
RGD:4889916 RGD:4889917 RGD:4889927 |
NCBI chr 8:45,029,011...45,055,185
|
|
| G
|
Il1b
|
interleukin 1 beta
|
susceptibility
|
ISO
|
mRNA:increased expression:nasal cavity epithelium associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human) associated with Hypersensitivity;protein:increased expression:nasal mucus
|
RGD |
PMID:10224452 PMID:14533660 PMID:20490816 |
RGD:4142821 RGD:4142859 RGD:4143227 |
NCBI chr 5:108,109,213...108,115,688
|
|
| G
|
Il1rl1
|
interleukin 1 receptor like 1
|
severity
|
ISO
|
associated with Sinusitis;DNA:SNPs: :multiple (human)
|
RGD |
PMID:19671251 |
RGD:5144228 |
NCBI chr 4:116,649,008...116,697,676
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
susceptibility
|
ISO
|
associated with Hypersensitivity;DNA:repeat:intron (human)
|
RGD |
PMID:10224452 PMID:14533660 PMID:15178892 |
RGD:4142859 RGD:4143215 RGD:4143227 |
NCBI chr 5:12,857,104...12,861,509
|
|
| G
|
Il2
|
interleukin 2
|
susceptibility
|
ISO
|
DNA:SNP:promoter:rs2069762(human)
|
RGD |
PMID:16333313 |
RGD:8663473 |
NCBI chr 3:116,891,667...116,896,372
|
|
| G
|
Il21
|
interleukin 21
|
|
ISO
|
|
RGD |
PMID:17982108 |
RGD:5147397 |
NCBI chr 3:116,779,438...116,787,031
|
|
| G
|
Il22
|
interleukin 22
|
severity
|
ISO
|
mRNA:increased expression:blood, mononuclear cell
|
RGD |
PMID:21535180 |
RGD:5147409 |
NCBI chr 1:196,297,650...196,302,835
|
|
| G
|
Il23r
|
interleukin 23 receptor
|
susceptibility
|
ISO
|
DNA:SNP,haplotype: :rs7517847(human)
|
RGD |
PMID:23696856 |
RGD:8549605 |
NCBI chr 6:76,970,947...77,058,358
|
|
| G
|
Il27ra
|
interleukin 27 receptor subunit alpha
|
|
ISO
|
|
RGD |
PMID:19354069 |
RGD:5128480 |
NCBI chr17:16,241,637...16,252,615
|
|
| G
|
Il4
|
interleukin 4
|
|
ISO
|
mRNA:increased expression:nasal cavity epithelium protein:increased expression:serum CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:18826099 PMID:19672097 PMID:21208219 |
RGD:2317285 RGD:5128558 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
|
ISO
|
DNA:polymorphism: :c.1432T>C (human)
|
RGD |
PMID:15564773 |
RGD:4890394 |
NCBI chr 2:76,354,040...76,366,181
|
|
| G
|
Il5
|
interleukin 5
|
|
ISO
|
|
RGD |
PMID:11884474 |
RGD:5128622 |
NCBI chr 9:36,201,293...36,204,023
|
|
| G
|
Il9
|
interleukin 9
|
|
ISO
|
|
RGD |
PMID:20525149 |
RGD:5128687 |
NCBI chr14:81,584,196...81,587,292
|
|
| G
|
Lep
|
leptin
|
|
ISO
|
|
RGD |
PMID:19860581 |
RGD:5128850 |
NCBI chr 6:110,485,308...110,499,224
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
susceptibility
|
ISO
|
DNA:polymorphism: :
|
RGD |
PMID:18831943 |
RGD:8693717 |
NCBI chr 2:30,336,702...30,342,648
|
|
| G
|
Mfn1
|
mitofusin 1
|
|
ISO
|
mRNA, protein:increased expression:nasal cavity mucosa (rat)
|
RGD |
PMID:28146064 |
RGD:13204839 |
NCBI chr 3:122,420,736...122,465,784
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
severity
|
ISO
|
protein:increased expression:serum, nasal mucosa
|
RGD |
PMID:15053202 PMID:15922619 |
RGD:4891045 RGD:4891056 |
NCBI chr18:11,580,563...11,581,554
|
|
| G
|
Ms4a2
|
membrane spanning 4-domains A2
|
|
ISO
|
|
RGD |
PMID:15480314 |
RGD:5131152 |
NCBI chr 2:11,238,992...11,245,945
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
ISO
|
mRNA:increased expression:nose
|
RGD |
PMID:15715404 PMID:20696593 |
RGD:4145454 RGD:7364740 |
NCBI chr 2:7,708,428...7,737,212
|
|
| G
|
Ngf
|
nerve growth factor
|
|
ISO
|
protein:increased expression:respiratory system fluid/secretion associated with Sinusitis;protein:increased expression:respiratory system mucosa
|
RGD |
PMID:10224365 PMID:19958603 |
RGD:4891064 RGD:4891115 |
NCBI chr 3:55,574,695...55,627,455
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
|
ISO
|
protein:increased expression:blood, eosinophil
|
RGD |
PMID:18647313 |
RGD:5144116 |
NCBI chr 9:58,799,000...58,816,269
|
|
| G
|
Nod1
|
nucleotide binding oligomerization domain containing 1
|
|
ISO
|
mRNA:decreased expression:nose
|
RGD |
PMID:20384614 |
RGD:5131446 |
NCBI chr 6:86,096,462...86,144,017
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
protein:increased expression:nasal mucosa
|
RGD |
PMID:18254476 |
RGD:4891910 |
NCBI chr 9:91,490,611...91,526,596
|
|
| G
|
Npy
|
neuropeptide Y
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12746121 |
|
NCBI chr 6:91,247,542...91,254,873
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
|
ISO
|
protein:increased expression:eosinophil
|
RGD |
PMID:18647313 |
RGD:5144116 |
NCBI chr 3:65,766,019...65,782,780
|
|
| G
|
Opa1
|
OPA1 mitochondrial dynamin like GTPase
|
|
ISO
|
mRNA, protein:increased expression:nasal cavity mucosa (rat)
|
RGD |
PMID:28146064 |
RGD:13204839 |
NCBI chr 4:14,478,312...14,556,210
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
mRNA:increased expression:nasal cavity epithelium
|
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr12:90,640,107...90,644,987
|
|
| G
|
Ptgdr2
|
prostaglandin D2 receptor 2
|
|
ISO
|
|
RGD |
PMID:19230460 PMID:19608418 |
RGD:5135017 RGD:5135021 |
NCBI chr 2:10,420,140...10,421,424
|
|
| G
|
Scgb3a2
|
secretoglobin family 3A member 2
|
|
ISO
|
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
|
RGD |
PMID:17218572 PMID:21385388 |
RGD:5144232 RGD:5147389 |
NCBI chr15:23,978,703...23,981,753
|
|
| G
|
Serpine1
|
serpin family E member 1
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:rs1799768 (human)
|
RGD |
PMID:19063817 |
RGD:4144832 |
NCBI chr16:16,947,758...16,958,217
|
|
| G
|
Sftpd
|
surfactant protein D
|
susceptibility
|
ISO
|
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
|
RGD |
PMID:19493231 |
RGD:4143494 |
NCBI chr13:19,689,837...19,703,507
|
|
| G
|
Tap1
|
transporter 1, ATP binding cassette subfamily B member
|
no_association susceptibility
|
ISO
|
DNA:SNPs: :
|
RGD |
PMID:12018331 PMID:17982230 |
RGD:6482262 RGD:6482274 |
NCBI chr18:8,088,841...8,139,516
|
|
| G
|
Tbxa2r
|
thromboxane A2 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12167471 |
|
NCBI chr 1:153,556,812...153,560,110
|
|
| G
|
Tgfb1
|
transforming growth factor beta 1
|
|
ISO
|
associated with Sinusitis
|
RGD |
PMID:18423831 |
RGD:4145277 |
NCBI chr 2:169,090,515...169,108,146
|
|
| G
|
Tlr2
|
toll like receptor 2
|
susceptibility no_association
|
ISO
|
DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa: associated with Sinusitis;DNA:SNPs: :multiple (human)
|
RGD |
PMID:18219831 PMID:19128592 PMID:19763595 |
RGD:4145354 RGD:4145356 RGD:7800742 |
NCBI chr 3:69,727,695...69,733,850
|
|
| G
|
Tlr6
|
toll like receptor 6
|
|
ISO
|
associated with Asthma;DNA:SNP: :rs2381289 (human)
|
RGD |
PMID:20815312 |
RGD:4145352 |
NCBI chr11:21,952,804...21,960,343
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
mRNA:increased expression:nose
|
RGD |
PMID:15120189 PMID:20696593 |
RGD:4143470 RGD:4145454 |
NCBI chr18:7,795,823...7,798,458
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
protein:increased expression:sputum
|
RGD |
PMID:19178538 |
RGD:6892723 |
NCBI chr 4:83,839,276...83,854,678
|
|
| G
|
Vip
|
vasoactive intestinal peptide
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12746121 PMID:14680090 |
|
NCBI chr 2:197,189,791...197,194,571
|
|
|
|
| G
|
Anxa1
|
annexin A1
|
|
ISO
|
associated with Nasal Polyps
|
RGD |
PMID:22279949 |
RGD:7421555 |
NCBI chr 2:20,396,186...20,412,032
|
|
| G
|
C3
|
complement C3
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:19593977 |
RGD:4889484 |
NCBI chr 4:88,610,382...88,636,268
|
|
| G
|
C4a
|
complement C4A (Chido/Rodgers blood group)
|
disease_progression
|
ISO
|
DNA:deletion: :
|
RGD |
PMID:16879240 |
RGD:5688262 |
NCBI chr18:7,405,116...7,419,413
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
|
ISO
|
|
RGD |
PMID:16702571 |
RGD:7483585 |
NCBI chr 4:155,953,398...155,955,460
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
susceptibility
|
ISO
|
DNA:haplotype::rs38850,rs38855,rs38857(human)
|
RGD |
PMID:20416453 |
RGD:8548615 |
NCBI chr 6:146,163,423...146,232,445
|
|
| G
|
Igf1
|
insulin like growth factor 1
|
|
ISO
|
mRNA:increased expression:nose:
|
RGD |
PMID:20713758 |
RGD:8548883 |
NCBI chr 1:166,967,436...167,046,403
|
|
| G
|
Il10
|
interleukin 10
|
|
ISO
|
protein:decreased expression:blood, mononuclear cell
|
RGD |
PMID:23168151 |
RGD:7364820 |
NCBI chr10:4,795,370...4,799,859
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
protein:increased expression:nasal cavity epithelium
|
RGD |
PMID:11197112 |
RGD:7401169 |
NCBI chr 5:108,109,213...108,115,688
|
|
| G
|
Il22ra1
|
interleukin 22 receptor subunit alpha 1
|
susceptibility
|
ISO
|
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
|
RGD |
PMID:19393422 |
RGD:5147411 |
NCBI chr 1:22,468,120...22,490,272
|
|
| G
|
Il4
|
interleukin 4
|
treatment
|
ISO
|
associated with Asthma
|
RGD |
PMID:12787306 |
RGD:7829803 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
|
RGD |
PMID:23401274 |
RGD:8547880 |
NCBI chr 5:153,004,445...153,048,368
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
treatment
|
ISO
|
|
RGD |
PMID:19389874 PMID:23131200 |
RGD:7349403 RGD:7364734 |
NCBI chr 2:7,708,428...7,737,212
|
|
| G
|
Prkra
|
protein activator of interferon induced protein kinase EIF2AK2
|
severity
|
ISO
|
associated with Nasal Polyps
|
RGD |
PMID:22961479 |
RGD:7777146 |
NCBI chr 5:53,977,526...53,997,153
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
ISO
|
protein:increased expression:nasal mucosa (human)
|
RGD |
PMID:21711960 |
RGD:6483796 |
NCBI chr16:16,947,758...16,958,217
|
|
| G
|
Tlr2
|
toll like receptor 2
|
susceptibility
|
ISO
|
DNA:polymorphisms:: rs3804099,rs3804100(human) mRNA,protein:increased expression:paranasal sinus
|
RGD |
PMID:21493395 PMID:22182736 |
RGD:7800733 RGD:8552975 |
NCBI chr 3:69,727,695...69,733,850
|
|
| G
|
Tlr4
|
toll like receptor 4
|
|
ISO
|
mRNA,protein:increased expression:paranasal sinus
|
RGD |
PMID:22182736 |
RGD:7800733 |
NCBI chr 1:86,484,628...86,497,678
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
protein:increased expression:nasal cavity epithelium
|
RGD |
PMID:11197112 PMID:20147558 |
RGD:7401169 RGD:7401236 |
NCBI chr18:7,795,823...7,798,458
|
|
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
ISO
|
|
RGD |
PMID:16677242 |
RGD:5147463 |
NCBI chr 6:30,246,881...30,296,065
|
|
| G
|
Apoa4
|
apolipoprotein A4
|
resistance
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:20810159 |
RGD:5685642 |
NCBI chr 8:40,760,793...40,763,289
|
|
| G
|
Bdnf
|
brain derived neurotrophic factor
|
severity
|
ISO
|
protein:increased expression:blood, nasal cavity epithelium
|
RGD |
PMID:18266897 |
RGD:5144117 |
NCBI chr 5:87,969,541...88,020,106
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
|
ISO
|
protein:increased expression:inferior turbinate, epithelium (human)
|
RGD |
PMID:20459697 |
RGD:4891379 |
NCBI chr 9:87,159,440...87,164,155
|
|
| G
|
Fga
|
fibrinogen alpha chain
|
|
ISO
|
|
RGD |
PMID:21887273 |
RGD:5688767 |
NCBI chr 3:70,491,353...70,498,618
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
treatment
|
ISO
|
DNA:SNP: :rs37973
|
RGD |
PMID:29981236 |
RGD:628359913 |
NCBI chr 6:129,816,197...129,883,811
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
|
ISO
|
protein:decreased expression;T lymphocyte:
|
RGD |
PMID:21410266 |
RGD:5491008 |
NCBI chr 2:47,362,784...47,372,699
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
protein:increased secretion:nasopharynx, secretion (human)
|
RGD |
PMID:20128420 |
RGD:4145459 |
NCBI chr 8:17,279,224...17,290,965
|
|
| G
|
Ifngr1
|
interferon gamma receptor 1
|
|
ISO
|
DNA: SNP: Leu467Pro
|
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr 2:216,963,207...216,981,834
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
ISO
|
|
RGD |
PMID:19505388 |
RGD:7365025 |
NCBI chr10:4,795,370...4,799,859
|
|
| G
|
Il18
|
interleukin 18
|
no_association susceptibility
|
ISO
|
DNA:SNPs:promoters:multiple DNA:SNPs:promoters, exon:multiple
|
RGD |
PMID:12532106 |
RGD:8655871 |
NCBI chr 8:45,029,011...45,055,185
|
|
| G
|
Il4
|
interleukin 4
|
|
ISO
|
protein:increased expression:serum mRNA:increased expression:nose:
|
RGD |
PMID:7551298 PMID:9237816 |
RGD:7829817 RGD:8662960 |
NCBI chr 9:36,098,574...36,104,434
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
ISO
|
protein:increased expression:nasal cavity of mucosa:
|
RGD |
PMID:17651148 |
RGD:8551771 |
NCBI chr11:32,697,838...32,740,235
|
|
| G
|
Mc1r
|
melanocortin 1 receptor
|
no_association
|
ISO
|
|
RGD |
PMID:20357480 |
RGD:5687317 |
NCBI chr17:43,016,520...43,017,473
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
|
RGD |
PMID:22237587 |
RGD:8547819 |
NCBI chr 5:153,004,445...153,048,368
|
|
| G
|
Nod1
|
nucleotide binding oligomerization domain containing 1
|
susceptibility
|
ISO
|
DNA:SNP: :rs2075817 (human)
|
RGD |
PMID:16918516 |
RGD:5131519 |
NCBI chr 6:86,096,462...86,144,017
|
|
| G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
|
ISO
|
protein:increased expression:respiratory system epithelium
|
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 5:13,224,081...13,245,665
|
|
| G
|
Scgb1a1
|
secretoglobin family 1A member 1
|
|
ISO
|
mRNA, protein:decreased expression:nasal lavage fluid
|
RGD |
PMID:15836756 |
RGD:5144234 |
NCBI chr 2:8,857,238...8,860,667
|
|
| G
|
Tlr3
|
toll like receptor 3
|
|
ISO
|
protein:decreased expression:bone marrow, blood, eosinophil (human)
|
RGD |
PMID:19752565 |
RGD:5129130 |
NCBI chr13:42,428,925...42,441,404
|
|
| G
|
Tlr4
|
toll like receptor 4
|
susceptibility
|
ISO
|
DNA:polymorphisms:cds:p.D299G, T399I (human)
|
RGD |
PMID:18517079 |
RGD:4144192 |
NCBI chr 1:86,484,628...86,497,678
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
|
RGD |
PMID:12633568 |
RGD:7483595 |
NCBI chr 4:83,839,276...83,854,678
|
|
|
|
| G
|
Maml3
|
mastermind like transcriptional coactivator 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24859338 |
|
NCBI chr 3:102,345,104...102,772,838
|
|
| G
|
Pax3
|
paired box 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24859338 |
|
NCBI chr 4:151,317,944...151,412,926
|
|
| G
|
Smarcb1
|
SWI/SNF related BAF chromatin remodeling complex subunit B1
|
|
ISO
|
|
RGD |
PMID:30120966 |
RGD:127285653 |
NCBI chr18:11,525,831...11,548,754
|
|